| Literature DB >> 32763179 |
Abstract
Senescence is a critical factor in several diseases, yet senolytic therapies targeting senescent cells remain hindered by lack of specificity. In the June issue of Nature, Amor et al. (2020) develop chimeric antigen receptor (CAR)-T cells targeting uPAR, a novel senescent-cell marker, to treat liver adenocarcinoma and liver fibrosis.Entities:
Mesh:
Year: 2020 PMID: 32763179 PMCID: PMC7717659 DOI: 10.1016/j.stem.2020.07.010
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633